IR-Med (IRME) Stock Statistics & Valuation Metrics

IR-Med has a market cap or net worth of $5.62M. The enterprise value is $5.71M.

IR-Med has 72,018,140 shares outstanding. The number of shares has decreased by -2.65% in one year.

IR-Med’s return on equity (ROE) is 6.46 and return on invested capital (ROIC) is 1416.79%.

The current PE Ratio of IR-Med is -17.35. IR-Med’s PEG ratio is -0.13.

In the last 12 months, IR-Med had revenue of 0.00 and earned -1.90M in profits. Earnings per share was -0.03.

In the last 12 months, operating cash flow was -1.14M and capital expenditures 0.00, giving a free cash flow of -1.14M billion.

IR-Med pays an annual dividend of ―, resulting in a dividend yield of ―

IR-Med upcoming earnings date is ―, TBA Not Confirmed.

IR-Med as a current ratio of 0.38, with Debt / Equity ratio of 0.00%

In the past 12 months, IR-Med has paid 0.00 in taxes.

IR-Med EV to EBITDA ratio is -17.59, with an EV/FCF ratio of -23.79.

IR-Med has $51.00K in cash and marketable securities with $0.00 in debt, giving a net cash position of -$51.00K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for IR-Med is ―, which is 11.43% higher than the current price. The consensus rating is ―